<DOC>
	<DOCNO>NCT01611311</DOCNO>
	<brief_summary>The primary objective current study investigate safety tolerability BI 409306 healthy young elderly male female volunteer follow oral administration repeat rise dos , give daily 14 day young healthy genotyped elderly healthy male/female volunteer .</brief_summary>
	<brief_title>Safety , Tolerability , Pharmacokinetics , Pharmacodynamics Multiple Rising Doses BI 409306</brief_title>
	<detailed_description />
	<criteria>Inclusion criterion : 1 . Healthy male/female subject Exclusion criterion : 1 . Any relevant deviation healthy condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>